Linyi Tumor Hospital

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

  NCT05353257· Phase 3· Source

• Recruiting

  Evaluate the Safety and Clinical Activity of HH2853

  NCT04390737· Phase 1/2· Source

• Active, not recruiting

  Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

  NCT02864992· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Follicular lymphoma1 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

  NCT03940703· Phase 2· Source